Hubei Biocause Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 000627.SZ

Hubei Biocause Pharmaceutical Co., Ltd. Share Price on January 14, 2025: USD 0.52

Hubei Biocause Pharmaceutical Co., Ltd. Share Price is USD 0.52 on January 14, 2025, a 34.94% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Hubei Biocause Pharmaceutical Co., Ltd. 52-week high Share Price is USD 0.71 on December 10, 2024, which is 38.57% above the current Share Price.
Hubei Biocause Pharmaceutical Co., Ltd. 52-week low Share Price is USD 0.23 on July 10, 2024, which is -56.28% below the current Share Price.
Hubei Biocause Pharmaceutical Co., Ltd. average Share Price for the last 52 weeks is USD 0.39.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

Shenzhen Stock Exchange: 000627.SZ

Hubei Biocause Pharmaceutical Co., Ltd.

CEO	Ms. Wenxia Zhou
IPO Date	Nov. 12, 1996
Location	China
Headquarters	#122 Yangwan Road
Employees	1,765
Sector	Health Care
Industries Pharmaceuticals

Description

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.

Key trends

Past 5 years